Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada
Author(s) -
Steven Habbous,
Xiaochen Tai,
Jaclyn Beca,
Jessica Arias,
Michael J. Raphael,
Ambica Parmar,
Andrea Crespo,
Matthew C. Cheung,
Andrea Eisen,
Antoine Eskander,
Simron Singh,
Maureen Trudeau,
Scott Gavura,
Wei Fang Dai,
Jonathan C. Irish,
Monika K. Krzyzanowska,
Lauren LapointeShaw,
Rohini Naipaul,
Stuart Peacock,
Lyndee Yeung,
Leta Forbes,
Kelvin Chan
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.25118
Subject(s) - term (time) , covid-19 , medicine , breast cancer , systemic therapy , oncology , cancer , neoadjuvant therapy , intensive care medicine , demography , disease , sociology , physics , quantum mechanics , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom